Ambri Company Description
Ambri Limited operates in a small, small world. The company develops biosensor technology, drawing on work from the fields of biotechnology, nanotechnology, and electronics; its primary technology is the Ion Channel Switch, a biosensing device. The Ion Channel Switch, or ICS, technology was developed using a membrane that acts as a switch, triggering an electrical current in the presence of particular molecules. Ambri plans to use the technology in point-of-care diagnostic products. The ICS was developed from research done by the Australian Membrane and Biotechnology Research Institute (AMBRI), the University of Sydney, and others.
View the Comprehensive Company Description for Ambri
The Company Description provides a historical perspective of Ambri's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Ambri's evolution in the marketplace.
